Benamax Flavour 20 mg tablets for dogs
Benamax Flavour 20 mg tablets for dogs
Authorised
- Benazepril hydrochloride
Product identification
Medicine name:
Benamax Flavour 20 mg tablets for dogs
Benefortin Flavour 20 mg Tablet
Benefortin Flavour 20 mg Comprimé
Benefortin Flavour 20 mg Tablette
Active substance:
- Benazepril hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Benazepril hydrochloride20.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
- PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
- PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
- PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lavet Pharmaceuticals Ltd.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V409437
Date of authorisation status change:
Reference member state:
-
Hungary
Procedure number:
- HU/V/0113/003
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
France
-
Germany
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: